Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 4/2023

17.09.2022

Hospital outcomes of patients receiving catheter ablation of atrial fibrillation, left atrial appendage closure, or both

verfasst von: Ramez Morcos, Haider Al Taii, Muni Rubens, Anshul Saxena, Venkataraghavan Ramamoorthy, Mohamed Hamed, Amr F. Barakat, Nitin Kulkarni, Houman Khalili, Santiago Garcia, Michael Megaly, Emir Veledar, Stavros Stavrakis

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Catheter ablation (CA) and left atrial appendage closure (LAAC) require transseptal access; combining both in a single procedure may have advantages. However, the safety of this approach has not been extensively studied. The objective of this study was to compare in hospital outcomes among patients receiving CA, LAAC, and combination of both treatments on the same day.

Methods

We conducted a retrospective cohort analysis of the National Inpatient Sample database. The primary outcome was the presence of major adverse cardiovascular and cerebrovascular events (MACCE) during index hospitalization. Secondary outcomes included stroke, pericardial effusion, pericardiocentesis, and bleeding.

Results

A total of 69,285 hospitalizations with AF were included in the analysis, of which 71.7% received LAAC, 27.8% received CA, and 0.5% received combination of both treatments on the same day. MACEE (OR, 1.63; 95% CI, 0.39–6.70), stroke (OR, 2.98; 95% CI, 0.55–16.01), pericardial effusion (OR, 0.33; 95% CI, 0.07–1.41), pericardiocentesis (OR, 1.00; 95% CI, 0.25–3.86), and bleeding (OR, 3.25; 95% CI, 0.87–12.07) did not differ significantly between CA and combination treatment. Similarly, MACCE (OR, 1.11; 95% CI, 0.28–4.41), stroke (OR, 1.03; 95% CI, 0.24–4.35), pericardial effusion (OR, 0.45; 95% CI, 0.11–1.90), pericardiocentesis (OR, 0.63; 95% CI, 0.14–2.83), and bleeding (OR, 2.04; 95% CI, 0.65–6.39) did not differ significantly between LAAC and combination treatment.

Conclusions

The combined approach is infrequently used in clinical practice (< 1%). However, major life-threatening adverse events did not differ between CA and LAAC when performed in isolation or combined in a single procedural stage on the same day.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.CrossRefPubMed Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.CrossRefPubMed
2.
Zurück zum Zitat Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420.CrossRefPubMed Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420.CrossRefPubMed
3.
Zurück zum Zitat Noseworthy PA, Kapa S, Haas LR, et al. Trends and predictors of readmission after catheter ablation for atrial fibrillation, 2009–2013. Am Heart J. 2015;170(3):483–9.CrossRefPubMed Noseworthy PA, Kapa S, Haas LR, et al. Trends and predictors of readmission after catheter ablation for atrial fibrillation, 2009–2013. Am Heart J. 2015;170(3):483–9.CrossRefPubMed
4.
Zurück zum Zitat Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012;59(2):143–9.CrossRefPubMedPubMedCentral Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012;59(2):143–9.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Wintgens LIS, Klaver MN, Swaans MJ, et al. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices. Europace. 2019;21(3):428–33.CrossRefPubMed Wintgens LIS, Klaver MN, Swaans MJ, et al. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices. Europace. 2019;21(3):428–33.CrossRefPubMed
6.
Zurück zum Zitat Gloekler S, Saw J, Koskinas KC, et al. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation. Int J Cardiol. 2017;249:234–46.CrossRefPubMed Gloekler S, Saw J, Koskinas KC, et al. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation. Int J Cardiol. 2017;249:234–46.CrossRefPubMed
7.
Zurück zum Zitat Liu J, Xia Y, Zhang H, Li X, Zhang S, Fang P. Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation. Herz. 2021;46(Suppl 1):82–8.CrossRefPubMed Liu J, Xia Y, Zhang H, Li X, Zhang S, Fang P. Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation. Herz. 2021;46(Suppl 1):82–8.CrossRefPubMed
8.
Zurück zum Zitat Boersma LV, Schmidt B, Betts TR, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016;37(31):2465–74.CrossRefPubMedPubMedCentral Boersma LV, Schmidt B, Betts TR, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016;37(31):2465–74.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Osmancik P, Herman D, Neuzil P, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(25):3122–35.CrossRefPubMed Osmancik P, Herman D, Neuzil P, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(25):3122–35.CrossRefPubMed
10.
Zurück zum Zitat Black-Maier E, Piccini JP, Granger CB. Left atrial appendage closure: a therapy uniquely suited for specific populations of patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30(12):2968–76.CrossRefPubMed Black-Maier E, Piccini JP, Granger CB. Left atrial appendage closure: a therapy uniquely suited for specific populations of patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30(12):2968–76.CrossRefPubMed
11.
Zurück zum Zitat Price MJ, Reddy VY, Valderrabano M, et al. Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience. JACC Cardiovasc Interv. 2015;8(15):1925–32.CrossRefPubMed Price MJ, Reddy VY, Valderrabano M, et al. Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience. JACC Cardiovasc Interv. 2015;8(15):1925–32.CrossRefPubMed
12.
Zurück zum Zitat Reddy VY, Doshi SK, Kar S, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70(24):2964–75.CrossRefPubMed Reddy VY, Doshi SK, Kar S, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70(24):2964–75.CrossRefPubMed
13.
Zurück zum Zitat Ren Z, Zhang J, Zhu M, et al. Cryoablation combined with left atrial appendage closure: a safe and effective procedure for paroxysmal atrial fibrillation patients. Cardiol Res Pract. 2020;2020:6573296.CrossRefPubMedPubMedCentral Ren Z, Zhang J, Zhu M, et al. Cryoablation combined with left atrial appendage closure: a safe and effective procedure for paroxysmal atrial fibrillation patients. Cardiol Res Pract. 2020;2020:6573296.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261–74.CrossRefPubMedPubMedCentral Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261–74.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Swaans MJ, Post MC, Rensing BJ, Boersma LV. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2012;1(5): e002212.CrossRefPubMedPubMedCentral Swaans MJ, Post MC, Rensing BJ, Boersma LV. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2012;1(5): e002212.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Fassini G, Conti S, Moltrasio M, et al. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016;18(11):1705–10.CrossRefPubMed Fassini G, Conti S, Moltrasio M, et al. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016;18(11):1705–10.CrossRefPubMed
17.
Zurück zum Zitat Phillips KP, Pokushalov E, Romanov A, et al. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up. Europace. 2018;20(6):949–55.CrossRefPubMed Phillips KP, Pokushalov E, Romanov A, et al. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up. Europace. 2018;20(6):949–55.CrossRefPubMed
18.
Zurück zum Zitat Ren Z, Zhang J, Wang S, et al. Two-year outcome from combining cryoballoon ablation and left atrial appendage closure: CLACBAC study. Front Cardiovasc Med. 2020;7: 610537.CrossRefPubMed Ren Z, Zhang J, Wang S, et al. Two-year outcome from combining cryoballoon ablation and left atrial appendage closure: CLACBAC study. Front Cardiovasc Med. 2020;7: 610537.CrossRefPubMed
19.
Zurück zum Zitat Calvo N, Salterain N, Arguedas H, et al. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation. Europace. 2015;17(10):1533–40.CrossRefPubMed Calvo N, Salterain N, Arguedas H, et al. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation. Europace. 2015;17(10):1533–40.CrossRefPubMed
20.
Zurück zum Zitat Du X, Chu H, Ye P, et al. Combination of left atrial appendage closure and catheter ablation in a single procedure for patients with atrial fibrillation: Multicenter experience. J Formos Med Assoc. 2019;118(5):891–7.CrossRefPubMed Du X, Chu H, Ye P, et al. Combination of left atrial appendage closure and catheter ablation in a single procedure for patients with atrial fibrillation: Multicenter experience. J Formos Med Assoc. 2019;118(5):891–7.CrossRefPubMed
22.
Zurück zum Zitat Brinjikji W, Rabinstein AA, Kallmes DF, Cloft HJ. Patient outcomes with endovascular embolectomy therapy for acute ischemic stroke: a study of the national inpatient sample: 2006 to 2008. Stroke. 2011;42(6):1648–52.CrossRefPubMed Brinjikji W, Rabinstein AA, Kallmes DF, Cloft HJ. Patient outcomes with endovascular embolectomy therapy for acute ischemic stroke: a study of the national inpatient sample: 2006 to 2008. Stroke. 2011;42(6):1648–52.CrossRefPubMed
23.
Zurück zum Zitat Ganesan AN, Shipp NJ, Brooks AG, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2): e004549.CrossRefPubMedPubMedCentral Ganesan AN, Shipp NJ, Brooks AG, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2): e004549.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312(19):1988–98.CrossRefPubMed Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312(19):1988–98.CrossRefPubMed
25.
Zurück zum Zitat Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.CrossRefPubMed Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.CrossRefPubMed
26.
Zurück zum Zitat Calvo N, Salterain N, Arguedas H, et al. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation. Ep Europace. 2015;17(10):1533–40.CrossRef Calvo N, Salterain N, Arguedas H, et al. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation. Ep Europace. 2015;17(10):1533–40.CrossRef
27.
Zurück zum Zitat Phillips KP, Pokushalov E, Romanov A, et al. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up. EP Europace. 2018;20(6):949–55.CrossRefPubMed Phillips KP, Pokushalov E, Romanov A, et al. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up. EP Europace. 2018;20(6):949–55.CrossRefPubMed
28.
Zurück zum Zitat Wintgens L, Romanov A, Phillips K, et al. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry. EP Europace. 2018;20(11):1783–9.CrossRefPubMed Wintgens L, Romanov A, Phillips K, et al. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry. EP Europace. 2018;20(11):1783–9.CrossRefPubMed
29.
Zurück zum Zitat Phillips KP, Walker DT, Humphries JA. Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience. J Arrhythmia. 2016;32(2):119–26.CrossRef Phillips KP, Walker DT, Humphries JA. Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience. J Arrhythmia. 2016;32(2):119–26.CrossRef
30.
Zurück zum Zitat Mo B-F, Sun J, Zhang P-P, et al. Combined therapy of catheter ablation and left atrial appendage closure for patients with atrial fibrillation: a case-control study. J Interv Cardiol. 2020;2020. Mo B-F, Sun J, Zhang P-P, et al. Combined therapy of catheter ablation and left atrial appendage closure for patients with atrial fibrillation: a case-control study. J Interv Cardiol. 2020;2020.
31.
Zurück zum Zitat Rovaris G, Ciconte G, Schiavone M, et al. Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study. Europace. 2021;23(9):1380–90.CrossRefPubMed Rovaris G, Ciconte G, Schiavone M, et al. Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study. Europace. 2021;23(9):1380–90.CrossRefPubMed
Metadaten
Titel
Hospital outcomes of patients receiving catheter ablation of atrial fibrillation, left atrial appendage closure, or both
verfasst von
Ramez Morcos
Haider Al Taii
Muni Rubens
Anshul Saxena
Venkataraghavan Ramamoorthy
Mohamed Hamed
Amr F. Barakat
Nitin Kulkarni
Houman Khalili
Santiago Garcia
Michael Megaly
Emir Veledar
Stavros Stavrakis
Publikationsdatum
17.09.2022
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 4/2023
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-022-01370-2

Weitere Artikel der Ausgabe 4/2023

Journal of Interventional Cardiac Electrophysiology 4/2023 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.